Ongoing
clinical
studies

Why participate in a clinical study?

icone bilan santé
HEALTH CHECKUP
icone entraide
TREATMENT QUALITY
icone équipe
DYNAMIC AND PASSIONATE TEAM
icone contribution scientifique
SCIENTIFIC CONTRIBUTION

DIDIER JUTRAS-ASWAD RESEARCH LABORATORY

The addiction psychiatry research unit (APRU), directed by Dr Didier Jutras-Aswad, head of the psychiatry department of the CHUM and clinical researcher, is conducting a dynamic clinical research program focused on psychoactive substances, mental health and drug addiction. This unit is made up of a multidisciplinary team, trained to the highest standards in clinical research. The team includes a researcher, a project manager, research coordinators, research assistants, scientific writers and graduate students.

April 2024

What do people with psychosis want in cannabis harm reduction interventions? Up to 60% of young people with psychosis uses cannabis, which is associated with significantly poorer clinical and psychosocial outcomes. While existing cannabis interventions

READ MORE
Research participants’ testimonies